Which hedge funds own NGNE? NEUROGENE INC, Q2 2026 13F holders
23 tracked hedge funds disclosed a position in NGNE (NEUROGENE INC) in their Q2 2026 13F filings, worth $314.0m in total. The largest holder by portfolio weight is Trails Edge Capital Partners, LP at 3.6% of its book. 6 opened a new position this quarter: Seven Fleet Capital Management LP, Moore Capital Management, LP, Trexquant Investment LP, ADAR1 Capital Management, LLC. 1 exited: Two Sigma Investments, LP.
- 23
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 6
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 1
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $12.5m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $280k
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $314m
- Combined value Sum of the holders' reported positions in the security.
- 1.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Two Sigma Investments, LP | 0.0% | $280k |
Ownership over time
Who discovered NGNE first? Beta
| Casdin Capital, LLC | Q1 2024 | +1.8 pts |
| Redmile Group, LLC | Q1 2024 | +1.0 pts |
| Cormorant Asset Management, LP | Q4 2023 | +0.8 pts |
| EcoR1 Capital, LLC | Q1 2024 | +0.6 pts |
| Avidity Partners Management LP | Q1 2024 | +0.5 pts |
| Octagon Capital Advisors LP | Q4 2024 | −0.3 pts |
| Great Point Partners LLC high conviction | Q1 2024 | −0.4 pts |
| Commodore Capital LP | Q1 2024 | −0.8 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.